Development and comparison of three 89Zr-labeled anti-CLDN18.2 antibodies to noninvasively evaluate CLDN18.2 expression in gastric cancer: a preclinical study. - Hu, Guilan; Zhu, Wenjia; Liu, Yu; Wang, Yuan; Zhang, Zheng; Zhu, Shikun; Duan, Wenwen; Zhou, Peipei; Fu, Chao; Li, Fang; Huo, Li (European Journal of Nuclear Medicine & Molecular Imaging, 2022)